Amicogen, Inc. (KOSDAQ: 092040)
South Korea
· Delayed Price · Currency is KRW
3,935.00
0.00 (0.00%)
At close: Dec 19, 2024
Amicogen Revenue
Amicogen had revenue of 39.90B KRW in the quarter ending September 30, 2024, a decrease of -7.52%. This brings the company's revenue in the last twelve months to 155.74B, down -5.18% year-over-year. In the year 2023, Amicogen had annual revenue of 159.90B with 10.82% growth.
Revenue (ttm)
155.74B
Revenue Growth
-5.18%
P/S Ratio
1.19
Revenue / Employee
692.17M
Employees
225
Market Cap
197.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 159.90B | 15.61B | 10.82% |
Dec 31, 2022 | 144.30B | 19.41B | 15.55% |
Dec 31, 2021 | 124.88B | 9.02B | 7.79% |
Dec 31, 2020 | 115.86B | 675.18M | 0.59% |
Dec 31, 2019 | 115.18B | 20.66B | 21.86% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition